Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease
Valeria Grancini(University of Milan), Emanuela Orsi(University of Milan), Maria Elena Lunati(ASST Fatebenefratelli Sacco), Dario Zimbalatti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Stefano Gatti, Maria Francesca Donato(University of Milan), Maddalena Trombetta(University of Verona), Veronica Resi(University of Milan), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessio Aghemo, Giuseppe Pugliese(Sapienza University of Rome), Maria Linda Boselli(University of Verona), Riccardo C. Bonadonna(Azienda Ospedaliera Universitaria Integrata Verona)
Cited by 75
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Insulin Causes Endothelial Dysfunction in Humans
|Circulation|2002|408
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|392